Insights into mechanisms of tumor dissemination from circulating tumor cell lines of small cell lung cancer

Abstract

Despite the fact that the majority of cancer patients succumb to metastatic disease, most aspects of tumor metastasis are not understood in detail at present. Cell biologic steps of dissemination are difficult to characterize in human tumors and research is in large part confined to cell line and experimental animal studies. Epithelial-mesenchymal transition (EMT), intravasation of malignant cells, dissemination as circulating tumor cells (CTCs) and eventually mesenchymal-epithelial transition (MET) at distal sites are steps believed to be involved in metastasis. Small cell lung cancer (SCLC) is distinguished by early dissemination and excessive numbers of CTCs, which allowed for the ex vivo expansion of six permanent CTC lines taken from relapsed patients. Cells exhibit an epithelial phenotype with partial EMT traits and are chemoresistant due to formation of large tumorospheres. Since cells may have invaded without undergoing EMT, the role of MET is uncertain. These SCLC CTC cell lines seem to represent the metastasis-inducing cancer cells; these are the minute subpopulation of CTCs capable of surviving in the circulation and transitioning to metastases, leading in turn to resistance and failure of therapy. Full characterization of these lines is expected to provide the markers to find the relevant CTCs among the highly heterogeneous population observable in the context of tumor recurrence.

Keywords

Cancer metastasis / small cell lung cancer / circulating tumor cells / epithelial-mesenchymal transition / tumorosphere / chemotherapy / drug resistance

References

[1] Pietanza MC,Minna JD.Small cell lung cancer: will recent progress lead to improved outcomes?.Clin Cancer Res2015;21:2244-55

[2] Karachaliou N,Molina-Vila MA.Real-time liquid biopsies become a reality in cancer treatment..Ann Transl Med2015;3:36

[3] Rolfo C,Hong D,Mertens I,Zwaenepoel K,Passiglia F,Taverna S,Santini D,Russo A.Liquid biopsies in lung cancer: the new ambrosia of researchers..Biochim Biophys Acta2014;1846:539-46

[4] Potdar PD.Role of circulating tumor cells in future diagnosis and therapy of cancer..J Cancer Metastasis Treat2015;1:44-56

[5] Yap TA,Omlin A,de Bono JS.Circulating tumour cells: a multifunctional biomarker..Clin Cancer Res2014;20:2553-68

[6] Hiltermann TJ,van den Berg A,Boezen HM,Schouwink JH,Kerner GS,Tissing H,Terstappen LW.Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor..Ann Oncol2012;23:2937-42

[7] Andree KC,Terstappen LW.Challenges in circulating tumor cell detection by the CellSearch system..Mol Oncol2016;10:395-407 PMCID:PMC5528971

[8] Paoletti C.Circulating tumor cells..Adv Exp Med Biol2016;882:235-58

[9] Ilie M,Long-Mira E,Vignaud JM,Mouroux J,Hofman P."Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease..PLoS One2014;9:e111597

[10] Gkountela S,Donato C.Recent advances in the biology of human circulating tumour cells and metastasis..ESMO Open2016;1:e000078

[11] Ferreira MM,Jeffrey SS.Circulating tumor cell technologies..Mol Oncol2016;10:374-94 PMCID:PMC5528969

[12] Leblanc R.Metastasis: new functional implications of platelets and megakaryocytes..Blood2016;128:24-31

[13] Krebs MG,Carter L,Blackhall FH.Molecular analysis of circulating tumour cells-biology and biomarkers..Nat Rev Clin Oncol2014;11:129-44

[14] Alix-Panabières C.Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy..Cancer Discov2016;6:479-91

[15] Bidard FC,Fehm T,Gisbert-Criado R,Grisanti S,Garcia-Saenz JA,Caldas C,Manso L,de Lascoiti AF,Ignatiadis M,van Laere SJ,Sandri MT,Politaki E,Bottini A,Krell J,Raimondi C,Janni W,Cara-ana V,Almici C,Solomayer EF,Johannes H,Pantel K,Michiels S.Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data..Lancet Oncol2014;15:406-14

[16] Sun YF,Zhou J,Fan J.Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance..J Cancer Res Clin Oncol2011;137:1151-73

[17] Polzer B,Pasch S,Zorzino L,Andergassen U,Czyz ZT,Treitschke S,Sergio M,Doffini A,Calanca A,Bolognesi C,Fasching PA,Rack B,Giorgini G,Klein CA.Molecular profiling of single circulating tumor cells with diagnostic intention..EMBO Mol Med2014;6:1371-86 PMCID:PMC4237466

[18] Karabacak NM,Fachin F,Pai V,Martel JM,Smith K,Yang J,Morgan B,Barber TA,Maheswaran S,Haber DA.Microfluidic, marker-free isolation of circulating tumour cells from blood samples..Nat Protoc2014;9:694-710 PMCID:PMC4179254

[19] Xu L,Imrali A,Mutsvangwa K,Cathcart P,Shamash J.Optimization and evaluation of a novel size based circulating tumor cell isolation system..PLoS One2015;10:e0138032

[20] Vona G,Louha M,Romana S,Capron F,Pazzagli M,Lacour B,Paterlini-Bréchot P.Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells..Am J Pathol2000;156:57-63

[21] Aceto N,Miyamoto DT,Wittner BS,Yu M,Engstrom A,Brannigan BW,Stott SL,Ramaswamy S,Lin CP,Haber DA.Circulating tumour cell clusters are oligoclonal precursors of breast cancer metastasis..Cell2014;158:1110-22 PMCID:PMC4149753

[22] Riethdorf S,Zhang L,Loibl S,Roller M,Fehm T,Hilfrich J,Tesch H,Untch M,Pantel K.Detection and HER2 expression of circulating tumour cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial..Clin Cancer Res2010;16:2634-45

[23] Krishnamurthy S,Ann Mayer J,Pham T,Lodhi A,Hall C.Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer..Cancer Med2013;2:226-33 PMCID:PMC3639661

[24] Krawczyk N,Banys M,Ruckhaeberle E.Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients..Biomed Res Int2014;2014:415721 PMCID:PMC4034492

[25] Smerage JB,Hortobagyi GN,Leyland-Jones B,Tejwani S,O'Rourke MA,Doyle GV,Livingston RB.Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500..J Clin Oncol2014;32:3483-9 PMCID:PMC4209100

[26] de Bono JS,Montgomery RB,Miller MC,Doyle GV,Pienta KJ.Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer..Clin Cancer Res2008;14:6302-9

[27] Moreno JG,Gross S,Gomella LG.Circulating tumor cells predict survival in patients with metastatic prostate cancer..Urology2005;65:713-8

[28] Molnar B,Tanko L,Tulassay Z.Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients..Clin Cancer Res2001;7:4080-5

[29] Hou JM,Ward T,Sloane R,Dive C.Circulating tumor cells, enumeration and beyond..Cancers (Basel)2010;2:1236-50 PMCID:PMC3835128

[30] Tanaka F,Hasegawa S.Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives..Lung Cancer Targets Ther2010;1:77-84

[31] Cheng M,Yang HS.Circulating tumor cellsare associated with bone metastasis of lung cancer..Asian Pac J Cancer Prev2014;15:6369-74

[32] Hodgkinson CL,Li Y,Rothwell DG,Polanski R,Simpson KL,Pepper SD,Greystoke A,Bola B,Antonello J,Faulkner S,Carter L,Miller CJ,Brady G.Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer..Nat Med2014;20:897-903

[33] Hamilton G,Zeillinger R.Circulating tumor cells in small cell lung cancer: ex vivo expansion.Lung2015;193:451-2

[34] Hamilton G,Klameth L.Small cell lung cancer: recruitment of macrophages by circulating tumor cells..Oncoimmunology2015;5:e1093277

[35] Butler TP.Quantitation of cell shedding into efferent blood of mammary adenocarcinoma..Cancer Res1975;35:512-6

[36] Meng S,Frenkel EP,Naftalis EZ,Beitsch PD,Hoover S,Haley B,Fleming TP,Terstappen LW,Tucker TF,Wang J.Circulating tumor cells in patients with breast cancer dormancy..Clin Cancer Res2004;10:8152-62

[37] Cohen SJ,Iannotti N,Sabbath KD,Picus J,Mitchell E,Doyle GV,Terstappen LW.Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer..Ann Oncol2009;20:1223-9

[38] Kahnert K,Huber RM.SCLC-state of the art and what does the future have in store?.Clin Lung Cancer2016;17:325-33

[39] Hamilton G,Holzer S.Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cell..Transl Lung Cancer Res2016;5:71-7

[40] Nieto MA,Jackson RA.EMT: 2016..Cell2016;166:21-45

[41] Tania M,Fu J.Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer..Tumour Biol2014;35:7335-42

[42] Hamilton G,Rath B,Zeillinger R.Small cell lung cancer: circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype..Cell Adh Migr2016;10:360-7 PMCID:PMC4986707

[43] Diepenbruck M.Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?.Curr Opin Cell Biol2016;43:7-13

[44] Valastyan S.Tumor metastasis: molecular insights and evolving paradigms..Cell2011;147:275-92 PMCID:PMC3261217

[45] Gunasinghe NP,Thompson EW.Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer..Cancer Metastasis Rev2012;31:469-78

[46] Khoo BL,Jing T,Lee SC,Han J.Liquid biopsy and therapeutic response: circulating tumor cell cultures for evaluation of anticancer treatment..Sci Adv2016;2:e1600274

[47] Weiswald LB,Dangles-Marie V.Spherical cancer models in tumor biology..Neoplasia2015;17:1-15 PMCID:PMC4309685

[48] Hamilton G,Hochmair M.Metastasis: circulating tumor cells in small cell lung cancer..Trends in Cancer2016;2:159-60

[49] Alvarado-Luna G.Treatment for small cell lung cancer, where are we now? - a review..Transl Lung Cancer Res2016;5:26-38

[50] Available at: https://clinicaltrials.gov; search term "SCLC", accessed 09/29/2016.

[51] Ruppen J,Strub C,Schmid RA,Guenat OT.Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform..Lab Chip2015;15:3076-85